De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases.
Crew
R John
RJ
Division of Nephrology, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA.
Radhakrishnan
Jai
J
Cohen
David J
DJ
Stern
Leonard
L
Goldstein
Michael
M
Hardy
Mark
M
D'Agati
Vivette D
VD
Markowitz
Glen S
GS
D001707:Biopsy, Needle; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007676:Kidney Failure, Chronic / Q000473:pathology / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D008297:Male; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000473:pathology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D020123:Sirolimus / Q000009:adverse effects* / Q000627:therapeutic use; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D020123:Sirolimus